Ciprofloxacin-ResistantSalmonella entericaSerovar Kentucky in Canada

• DOI: 10.3201/eid1906.121351
• Publication Date: 2013-05-03T16:43:14Z
• Authors: Michael R. Mulvey; David A. Boyd; Rita Finley; Ken Fakharuddin; Stacie Langner; Vanessa Allen; Lei Ang; Sadjia Bekal; Sameh El Bailey; David Haldane; Linda Hoang; Greg Horsman; Marie Louis; Lourens Robberts; John Wylie
• Keywords: Adult; 0301 basic medicine; Canada; Adolescent; Infectious and parasitic diseases; RC109-216; Microbial Sensitivity Tests; Young Adult; 03 medical and health sciences; Anti-Infective Agents; Salmonella genomic island; Ciprofloxacin; Drug Resistance, Bacterial; Humans; ciprofloxacin resistance; bacteria; Aged; multidrug resistant; R; Dispatch; Salmonella enterica; Middle Aged; 3. Good health; Salmonella Infections; Salmonella enterica serovar Kentucky; Medicine; Multilocus Sequence Typing

We report emergence of ciprofloxacin-resistant Salmonella enterica serovar Kentucky in Canada during 2003-2009. All isolates had similar macrorestriction patterns and were multilocus sequence type ST198, which has been observed in Europe and Africa. Ciprofloxacin-resistant S. enterica serovar Kentucky represents 66% of all ciprofloxacin-resistant nontyphoidal Salmonella sp. isolates observed in Canada since 2003.